LINDA PEABODY: Open Payments
NPI 1104201417 · DULUTH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$559 in 25 payments from 14 companies in 2025. Trend: 2023 $677 · 2024 $931 · 2025 $559
Food & beverage: $559
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $176 |
| Astellas Pharma US Inc | 3 | $65 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Lilly USA, LLC | 2 | $43 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| PFIZER INC. | 1 | $25 |
| Exact Sciences Corporation | 1 | $21 |
| Acella Pharmaceuticals, LLC | 1 | $19 |
| Dexcom, Inc. | 1 | $18 |
Products named: Ozempic, Veozah, REXULTI, Auvelity, ZEPBOUND, PREVNAR 20, Cologuard Collection Kit, Wegovy.
Industry payments across GA — which companies pay providers there.
